I'm interested in MilliporeSigma's Contract Manufacturing services for biologics. Please provide details on their main manufacturing sites for monoclonal antibodies (mAbs) and viral/gene therapies. For the mAb manufacturing site in Europe, what is its name, location, GMP experience in years, and what types of molecules does it produce? For the viral and gene therapy manufacturing site in North America, what is its name, location, square footage, and the manufacturing phases it supports?
Navigate to 'https://www.emdmillipore.com'. Click on the 'Services' button in the main navigation. Click on the 'Contract Manufacturing' link. On the Contract Manufacturing page, scroll down to the 'Focused Leadership Across Modalities' section and click on the 'mAb & r-Protein' tab. Scroll down to 'The Global Footprint of Our CTDMO Manufacturing Sites' section. Locate and expand the 'Europe' section (if not already expanded) by clicking the 'Europe' button. From the 'Europe' section, identify the main mAb manufacturing site (Martillac, France) and extract its name, location, years of GMP experience, and the types of molecules it handles. Locate and expand the 'North America' section (if not already expanded) by clicking the 'North America' button. From the 'North America' section, identify the main viral and gene therapy manufacturing site (Carlsbad, CA, USA) and extract its name, location, square footage, and the manufacturing phases it supports. Synthesize all gathered information into a concise answer.
The agent successfully navigates to the 'Services' section. The agent successfully navigates to the 'Contract Manufacturing' page. The agent successfully navigates to the 'mAb & r-Protein' tab. The agent successfully locates and extracts information from the 'Europe' section for mAb manufacturing. The agent states that the main mAb manufacturing site is Martillac, France, has '25+ years of GMP experience', and handles 'mAbs' (monoclonal antibodies) as its primary product. The agent successfully locates and extracts information from the 'North America' section for viral and gene therapy manufacturing. The agent states that the main viral and gene therapy manufacturing site is Carlsbad, CA, USA, is '157,000 sq. ft', and supports 'early phase to commercial manufacturing'.